Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
45
|
| pubmed:dateCreated |
1987-12-23
|
| pubmed:abstractText |
Vasomotor headaches are commonly, especially in the international literature, classified under ordinary migraine. Since beta-blockers seem to be the drug of choice in the prevention of migraine, 30 patients were given placebo and three times 40 mg propranolol in a double-blind cross-over trial. Among 24 fully assessable sets of tests only four showed a decrease in the frequency of headaches by more than 50%. In three patients the frequency actually increased over the placebo effect.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0012-0472
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
6
|
| pubmed:volume |
112
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1740-3
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:2890509-Adrenergic beta-Antagonists,
pubmed-meshheading:2890509-Adult,
pubmed-meshheading:2890509-Clinical Trials as Topic,
pubmed-meshheading:2890509-Cluster Headache,
pubmed-meshheading:2890509-Double-Blind Method,
pubmed-meshheading:2890509-Female,
pubmed-meshheading:2890509-Humans,
pubmed-meshheading:2890509-Male,
pubmed-meshheading:2890509-Middle Aged,
pubmed-meshheading:2890509-Placebos,
pubmed-meshheading:2890509-Propranolol,
pubmed-meshheading:2890509-Research Design,
pubmed-meshheading:2890509-Vascular Headaches
|
| pubmed:year |
1987
|
| pubmed:articleTitle |
[Betablocker vs placebo in vasomotor headache. A double-blind crossover study].
|
| pubmed:affiliation |
Klinik und Poliklinik für Neurologie der Universität Münster.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Controlled Clinical Trial
|